InMed Pharmaceuticals Operating Margin Growth & History (INM)

InMed Pharmaceuticals's operating margin was −160.20% for fiscal 2025.

View full InMed Pharmaceuticals company overview

InMed Pharmaceuticals annual operating margin history

InMed Pharmaceuticals annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20252025-06-30−160.20%+16.72 pp
20242024-06-30−176.92%+405.00 pp
20232023-06-30−581.92%+779.97 pp
20222022-06-30−1,361.89%−826.02 pp
20212021-06-30−535.87%—

InMed Pharmaceuticals operating margin trends

Between the periods ended 2021-06-30 and 2025-06-30, InMed Pharmaceuticals's operating margin increased from −535.87% to −160.20%, a change of +375.67 percentage points. The latest reported quarter, Q2 2026, shows −258.57%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review InMed Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about INM yet. Start the conversation.

Write the first post